Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000085778 | SCV000322151 | pathogenic | not provided | 2019-08-30 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect with significantly reduced ATPase activity compared to wild type (Sun et al., 2000); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 28365912, 23755871, 19028736, 11017087, 11527935, 17325136, 10958763, 27739528, 29555955, 9781034, 16917483, 29925512, 32141364, 31456290, 32845050) |
Invitae | RCV000085778 | SCV001230080 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1977 of the ABCA4 protein (p.Gly1977Ser). This variant is present in population databases (rs61750639, gnomAD 0.003%). This missense change has been observed in individual(s) with Stargardt disease (PMID: 9781034, 23755871, 27739528, 29925512). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99421). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001075771 | SCV001241403 | pathogenic | Retinal dystrophy | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000085778 | SCV001448013 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001075771 | SCV004706470 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Retina International | RCV000085778 | SCV000117920 | not provided | not provided | no assertion provided | not provided | ||
Sharon lab, |
RCV001002809 | SCV001160821 | likely pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research |